How much improvement in survival with newer agents?

This forum made possible through the generous support of SDN members, donors, and sponsors. Thank you.

thesauce

Senior Member
15+ Year Member
Joined
Aug 5, 2005
Messages
3,637
Reaction score
1,141
Hi guys,

I was wondering if anyone has run across a table (or other visual) which lays out the improvement in survival for NSCLC provided by some of the newer agents (immunotherapies, etc)? I just want to put the benefit of early palliative referrals in perspective for a presentation that I'm giving.

Something like this but with a few more drugs listed: http://jtd.amegroups.com/article/viewFile/106/188/698

Members don't see this ad.
 
Nothing has changed after this in NSCLC.
6b0e68fa00.jpg
 
Top